日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

New antihistamines - perspectives in the treatment of some allergic and inflammatory disorders

新型抗组胺药——治疗某些过敏性和炎症性疾病的前景

Tatarkiewicz, Jan; Rzodkiewicz, Przemysław; Żochowska, Małgorzata; Staniszewska, Anna; Bujalska-Zadrożny, Magdalena

New agents approved for treatment of acute staphylococcal skin infections

获批用于治疗急性葡萄球菌皮肤感染的新药

Tatarkiewicz, Jan; Staniszewska, Anna; Bujalska-Zadrożny, Magdalena

A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents

一种新型长效葡萄糖依赖性促胰岛素肽类似物:在正常和糖尿病啮齿动物中疗效增强

Tatarkiewicz, K; Hargrove, D M; Jodka, C M; Gedulin, B R; Smith, P A; Hoyt, J A; Lwin, A; Collins, L; Mamedova, L; Levy, O E; D'Souza, L; Janssen, S; Srivastava, V; Ghosh, S S; Parkes, D G

Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice

艾塞那肽和达格列净联合用药对糖尿病小鼠的抗糖尿病益处

Tatarkiewicz, K; Polizzi, C; Villescaz, C; D'Souza, L J; Wang, Y; Janssen, S; Parkes, D G

Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of action

具有肽白蛋白结合域的新型艾塞那肽类似物:具有延长作用时间的强效抗糖尿病药物

Odile E Levy, Carolyn M Jodka, Shijun Steven Ren, Lala Mamedova, Abhinandini Sharma, Manoj Samant, Lawrence J D'Souza, Christopher J Soares, Diane R Yuskin, Li Jenny Jin, David G Parkes, Krystyna Tatarkiewicz, Soumitra S Ghosh

No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks

接受艾塞那肽治疗 13 周的大鼠未出现药物性胰腺炎的证据

Tatarkiewicz, K; Belanger, P; Gu, G; Parkes, D; Roy, D

Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids

具有双重作用机制的肽杂合物可改善啮齿动物的血糖控制并降低体重

Trevaskis, James L; Mack, Christine M; Sun, Chengzao; Soares, Christopher J; D'Souza, Lawrence J; Levy, Odile E; Lewis, Diane Y; Jodka, Carolyn M; Tatarkiewicz, Krystyna; Gedulin, Bronislava; Gupta, Swati; Wittmer, Carrie; Hanley, Michael; Forood, Bruce; Parkes, David G; Ghosh, Soumitra S